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(84%) patients. PTX was diagnosed in 10 (23%) patients by 
CXR. There was complete agreement between radiologists 
interpreting CXR ( k = 1, 95% CI 1). Chest US was positive for 
PTX in 11 (25%) patients. There was complete agreement be-
tween pulmonologists interpreting chest US ( k = 1, 95% CI 
1). The prevalence of PTX diagnosed by concordance of CXR 
and chest US was 23% (10/43, 95% CI 11.8–38.7). The sensi-
tivity and specificity of chest US were 90% (95% CI 55.5–99.7) 
and 94% (95% CI 79.8–99.3), respectively. Moreover, the pos-
itive and negative predictive values were 82% (95% CI 48–
98) and 97% (95% CI 84–100), respectively.  Conclusion: 
Chest US is a highly sensitive and specific diagnostic tool for 
the diagnosis of PTX after TBLC.  © 2017 S. Karger AG, Basel 
 Introduction 
 According to American Thoracic Society/European 
Respiratory Society international guidelines, surgical 
lung biopsy (SLB) is indicated in diffuse parenchymal 
lung diseases (DPLDs) when a confident noninvasive di-
agnosis cannot be made. However, SLB has appreciable 
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 Abstract 
 Background: Transbronchial lung cryobiopsy (TBLC) can be 
indicated in diffuse parenchymal lung diseases (DPLDs) 
when a confident noninvasive diagnosis cannot be made. 
The 2 most relevant complications of TBLC are bleeding and 
pneumothorax (PTX). The accuracy of chest ultrasonography 
(US) for the detection of PTX is higher when compared to 
chest X-ray (CXR) with reference to computed tomography 
(CT) scan as a gold standard.  Objective: We evaluated the 
accuracy of chest US in detecting PTX after TBLC in patients 
with DPLDs.  Methods: Patients underwent TBLC during rigid 
bronchoscopy in deep sedation. Cryobiopsy was performed 
with fluoroscopic guidance. Three hours later, patients un-
derwent chest US and standard CXR. When there was no 
concordance between chest US and CXR, chest CT was re-
quired.  Results: Forty-three patients were enrolled into the 
study. Cryobiopsy was performed in the right lung in 36 
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costs and risks (including a mortality of 1.7% within 90 
days for elective procedures)  [1] . The majority of subjects 
are excluded because of advanced age, comorbidities, se-
vere respiratory impairment, and pulmonary hyperten-
sion, and a considerable minority refuse to undergo sur-
gery. Transbronchial lung cryobiopsy (TBLC) has clearly 
demonstrated a superior diagnostic yield in comparison 
to conventional forceps biopsy (80 vs. 30%)  [2, 3] , close 
to that of SLB (98%)  [4] . Mortality of TBLC is significant-
ly lower than that of SLB (0.1 vs. 1.7%)  [3] . All other com-
plications (fever, transient respiratory failure, and empy-
ema), hospitalization lengths, and costs are significantly 
lower for TBLC than for SLB. For all these reasons, TBLC 
is significantly changing the diagnostic algorithm of 
DPLDs and in many expert centers has already replaced 
SLB in the vast majority of cases.
 When dealing with TBLC, the 2 most relevant com-
plications that need to be timely and properly managed 
are bleeding and pneumothorax (PTX). PTX is very rare 
during bronchoscopy with transbronchial biopsy (2–
10%)  [5] . The prevalence of PTX after cryobiopsy varies 
from 4.9 to 20.2% in patients with DPLD  [3, 6–8] . Some 
studies have shown that development of PTX occurs 
within the first hour after the procedure, even though it 
might be invisible on chest X-rays (CXRs) performed im-
mediately after bronchoscopy; there is no evidence of the 
occurrence of PTX even after 4 h by transbronchial bi-
opsy  [9] .
 CXR used routinely for PTX diagnosis has a sensitiv-
ity of 46%  [10] ; the classic posterior-anterior projection 
in more difficult cases may be associated with a lateral 
view, and expiratory X-ray is not necessary  [11] . Chest 
computed tomography (CT) represents the gold standard 
for the diagnosis of PTX. In recent years, use of chest ul-
trasonography (US) has spread for the diagnosis of PTX; 
it reaches a pooled sensitivity of 87% (95% CI 81–92%) 
and a specificity of 99% (95% CI 98–99)  [12] according to 
a standardized method searching for specific pathogno-
monic signs  [13] .
 Chest US has more diagnostic power than CXR with 
reference to CT scan as a gold standard. Moreover, accu-
racy of US for the detection of PTX is higher than that of 
CXR with reference to CT scan as a gold standard. How-
ever, although CT is more sensitive than CXR, it is per-
formed only in uncertain cases to avoid excess of radia-
tion in often young patients  [1] .
 Chest US in PTX diagnosis after TBLC has never been 
evaluated, but its use in place of traditional CXR would 
have some advantages, avoiding exposure to radiation 
and reducing costs of health care and hospital stay. This 
study aims to evaluate the accuracy of chest US in detect-
ing PTX after TBLC in patients with DPLD. Secondary 
aims of this study are to assess postprocedure PTX preva-
lence and concordance between operators for both CXR 
and chest US in detecting PTX.
 Materials and Methods 
 We enrolled patients with DPLD who underwent TBLC for a 
definite diagnosis from December 2015 to February 2016 at the 
Interventional Pulmonology Unit, Morgagni Hospital in Forlì, 
 Italy. Patients had to be at least 18 years old, with a forced vital 
 capacity >50% of the predicted normal value. Patients with coagu-
lopathy (platelet count <70,000 " 10 9 /L, prothrombin time inter-
national normalized ratio >1.5), diffuse bullous disease, hemo dy-
namic instability, and severe hypoxemia (PaO 2 <50 mm Hg on 
room air) as well as pregnant patients were excluded.
 The following clinical and functional data were collected: age, 
cigarette smoking and pack years, weight, height, body mass index, 
oxygen saturation on room air, vital capacity, forced vital capacity, 
forced expiratory volume in 1 s, diffusing lung capacity for carbon 
monoxide, functional residual capacity, total lung capacity, and 
residual volume. Radiological data collected in the CT scan per-
formed in the last 2 months were lobular location of honey comb-
ing, subpleural cysts, and emphysema. 
 Patients underwent TBLC during rigid bronchoscopy in deep 
sedation with assistance of an anesthesiologist as previously pub-
lished  [14] . Cryobiopsy was performed with fluoroscopic guidance 
that can also immediately rule out postprocedure massive PTX. 
Fluoroscopic imaging was interpreted by the interventional pul-
monologist.
 Three hours after the procedure, patients underwent the fol-
lowing examinations:
 – Arterial oxygen saturation (SaO 2 ) evaluation. 
 – Chest US performed by 2 resident pulmonologists who attend-
ed a 3-day theoretical and practical chest US course and per-
formed 30 chest US to achieve competency before starting this 
study  [15] . Pulmonologists were blinded to the site of cryobi-
opsy and colleagues’ chest US results. Sonoscape SSI-600 with 
a 5- to 10-MHz linear probe was used in patients in supine po-
sition. US images were studied in a longitudinal and transversal 
scanning plane. Examinations were carried out from the clavi-
cle to the diaphragm at the intercostal spaces on both hemitho-
raxes in parasternal, midclavicular, anterior axillary, and 
midaxillary lines in B-mode and M-mode scans. The combina-
tion of 4 ultrasonographic signs allowed the pulmonologist to 
identify PTX. These signs were: (1) presence of lung point(s), 
(2) absence of lung sliding, (3) absence of B-lines, (4) absence 
of lung pulse, and (5) “stratosphere sign”  [16] .  
 – Standard CXR in posterior-anterior projection with the patient 
in the orthostatic position in exhalation and inhalation. CXR 
was interpreted by the radiologist on duty and reviewed by a 
second blinded radiologist. Radiologists were blinded also to 
chest US results.  
 If PTX was clinically suspected before the time by the attending 
physician, these exams were preponed. When there was no con-
cordance between chest US and CXR, chest CT was required.





 Statistical Analysis 
 The population is described with descriptive statistics. Con-
tinuous variables are expressed as medians and standard devia-
tions, while categorical variables are expressed as frequency and 
percentage. Cohen # statistics were calculated to evaluate the in-
terobserver agreement of investigators.
 Sensitivity, specificity, positive and negative predictive value, as 
well as disease prevalence are expressed as percentages. Their con-
fidence intervals are exact Clopper-Pearson confidence intervals. 
Receiver operating characteristic curve was also obtained. The sig-
nificance level was set at  p < 0.05.
 Statement of Ethics 
 The study protocol was approved by the local ethical commit-
tee (CE IRST IRCCS – AVR, protocol No. 2015/0289377/P). In-
formed consent was obtained from all subjects enrolled.
 Results 
 Forty-four patients were screened, and 43 were en-
rolled into the study. One patient was excluded because 
of a final diagnosis of lung cancer. Clinical and function-
al data of patients are described in  Table!1 . 
 Cryobiopsy was performed in the right lung in 36 (84%) 
patients and in the left lung in 7 (16%). PTX was diagnosed 
in 10 (23%) patients by CXR. There was complete agree-
ment between radiologists interpreting CXR ( k = 1, 95% CI 
1). All PTX occurred in the right hemithorax. A chest tube 
was inserted in 4 subjects (40% of the PTX group). 
 Chest US was positive for PTX in 11 (25%) patients. 
There was complete agreement between pulmonologists 
interpreting chest US ( k = 1, 95% CI 1). All cases of PTX 
detected in B-mode and defined by the absence of both 
lung sliding and B-lines were characterized also by 
“stratosphere sign” that replaced “seashore sign” in M-
mode  [17] . 
 All PTX requiring drainage were detected by chest US. 
A massive PTX was diagnosed with fluoroscopy and clin-
ical features in 1 patient. Immediately, chest US was per-
formed (positive for PTX), and a chest tube was inserted.
 In 4 (9%) patients, there was not concordance between 
CXR and chest US for the detection of PTX, but the pa-
tients refused to perform a chest CT because clinical and 
functional parameters were normal and they preferred to 
avoid radiation. One patient (2%) was negative on chest 
US and positive on CXR only in the expiratory scan (PTX 
4 mm). Three patients (6%) were positive on chest US 
(presence of lung point) and negative on CXR. One of 
these developed acute dyspnea 5 h after cryobiopsy. The 
patient underwent a second CXR that detected PTX, and 
a chest tube was inserted. 
 Table 1.  Clinical and functional data
Patients’ clinical features
Total, n 43
Age, years 63 ± 12
Male/female, n 26/17
BMI 27 ± 4
VC, % 86 ± 17
FVC, % 83 ± 18
FEV1, % 87 ± 18
TLC, % 76 ± 16
FRC, % 76 ± 26
RV, % 69 ± 42
DLCO, % 55 ± 19
PaO2, % (before biopsy) 96 ± 3
Smokers, n 24
Pack/years 33 ± 22
Samples for patient 3.5 ± 1.1
 Values are means ± standard deviations unless otherwise 
indicated. BMI, body mass index (in kg/m2); VC, vital capacity; 
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; 
TLC, total lung capacity; FRC, functional residual capacity; RV, 
residual volume; DLCO, diffusing lung capacity for carbon 
monoxide; PaO2, arterial pressure of oxygen.
 Table 2. US results for the diagnosis of PTX
PTX yes (n = 10) PTX no (n = 33)
US correct positive 9 US false positive 2
US false negative 1 US correct negative 31
Total 10 Total 33
US, ultrasound; PTX, pneumothorax.
 Table 3. Chest US diagnostic performance in the detection of PTX
 Ind ex Value 95% CI
Sensitivity, % 90 55.5 – 99.7
Specificity, % 94 79.8 – 99.3
Positive likelihood ratio 14.8 3.8 – 57.8
Negative likelihood ratio 0.1 0 – 0.6
Positive predictive value, % 82 48 – 98
Negative predictive value, % 97 84 – 100
US, ultrasound; PTX, pneumothorax; CI confidence interval.
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 The prevalence of PTX diagnosed by concordance of 
CXR and chest US was 23% (10/43, 95% CI 11.8–38.7). 
The diagnostic performance of chest US in PTX detection 
is reported in  Tables 2 and  3 .
 The analysis showed that the sensitivity and specificity 
of chest US were 90% (95% CI 55.5–99.7) and 94% (95% 
CI 79.8–99.3), respectively. Moreover, the positive and 
negative predictive values were 82% (95% CI 48–98) and 
97% (95% CI 84–100), respectively. The area under the 
receiver operating characteristic curve for chest US was 
0.92 (95% CI 0.79–0.98;  Z test:  p < 0.0001).
 The final multidisciplinary interstitial lung disease di-
agnosis is reported in  Table!4 . Idiopathic pulmonary fi-
brosis was diagnosed in 42% of patients, and 39% of them 
developed PTX after TBLC.
 Discussion 
 In this prospective pilot study, we showed that chest 
US is feasible and accurate for the detection of PTX after 
TBLC in patients with DPLD. To our knowledge, this is 
the first experience reported in the literature. In particu-
lar, the rapid bedside detection of the absence of both slid-
ing sign and B-lines in patients who usually showed dif-
fuse and bilateral vertical artifacts  [17–20] could optimize 
the postprocedural management of patients with DPLD 
who underwent TBLC.
 The larger sample of the lung parenchyma resulting 
from a TBLC is expected to increase the risk of PTX sig-
nificantly as compared to flexible forceps biopsy. The 
prevalence of PTX varies from 4.9 to 20.2%  [3, 6–8] . The 
rate of PTX after TBLC is higher than the usually report-
ed rate observed with the flexible forceps biopsy  [21–26] . 
Our group described a prevalence of PTX of 23%, and the 
incidence of PTX was independent of the number and 
size of the biopsy sample  [27, 28] .
 In our study, PTX occurred in one-fourth of cases. The 
higher incidence of PTX, compared to previously men-
tioned ones  [3, 6–8] , may be partly explained by a high 
percentage of patients who suffered from idiopathic pul-
monary fibrosis enrolled in the study (42%).
 The first experience with the accuracy of chest US in 
the diagnosis of postinterventional PTX and a compari-
son to CXR in patients who underwent transbronchial 
biopsy were reported by Reissig and Kroegel  [29] in 2005. 
Subsequently, Kreuter et al.  [30] evaluated the signifi-
cance of US of the chest in the diagnosis of PTX supple-
mented by power color Doppler imaging. The authors 
found high values of sensitivity, specificity, and accuracy 
of chest US with reference to CXR as a gold standard. A 
more recent report by Kumar et al.  [23] prospectively 
evaluated the accuracy of chest US in the detection of PTX 
after transbronchial lung biopsy. The authors demon-
strated a good sensitivity of US in detecting PTX follow-
ing transbronchial lung biopsy. A limitation of this study 
was a lack of comparative chest CT when there was no 
concordance between US and CXR; however, in 3 pa-
tients positive on US and negative on CXR, the presence 
of lung points allowed PTX diagnosis with a high degree 
of confidence. 
 Our findings of diagnostic accuracy of chest US for the 
diagnosis of postprocedural PTX corroborate the results 
of prior studies. A novel aspect of this study is that we ex-
tended the advantages of US to patients suffering from 
DPLD and undergoing TBLC for a definitive diagnosis. 
Particularly, our approach exploits the ready availability 
of US that allows the pulmonologist who performed the 
bronchoscopy to detect postprocedural PTX within a 
short time and optimizes the use of ionizing radiation. 
The main conclusion of our work is that chest US is a 
highly sensitive and specific diagnostic tool for the diag-
nosis of PTX after TBLC.
 
 Table 4. Final diagnosis of interstitial lung disease from 
multidisciplinary discussion
Final multidisciplinary diagnosis n % Rate of PTX
IPF 18 42 7 (70%)
OP 4 9 1 (10%)
SRIF 4 9 0
HP 3 7 1 (10%)
NSIP 2 5 1 (10%)
Lymphoma 2 5 0
Bronchioliotis 2 5 0
Sarcoidosis 2 5 0
CPFE 1 2 0
IgG4-RD 1 2 0
IPAF 1 2 0
PVOD 1 2 0
Eosinophilic pneumonia 1 2 0
Nondiagnostic 1 2 0
PTX, pneumothorax; IPF, idiopathic pulmonary fibrosis; OP, 
organizing pneumonia; SRIF, smoking-related interstitial fibrosis; 
HP, hypersensitivity pneumonitis; NSIP, nonspecific interstitial 
pneumonia; CPFE, combined pulmonary fibrosis and emphysema 
syndrome; IgG4-RD, immunoglobulin G4-related disease; IPAF, 
interstitial pneumonia with autoimmune features; PVOD, 
pulmonary veno-occlusive disease.
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